Top Markets
Coin of the day
Zhong Ji Longevity Science Group Limited Zhong Ji Longevity Science Group Limited

Zhong Ji Longevity Science Group Limited

0767
Classement en actions #26538
Zhong Ji Longevity Science Group Limited operates as an investment holding... Zhong Ji Longevity Science Group Limited operates as an investment holding entity, engaging in a broad spectrum of commercial endeavors. Its operations include providing money lending solutions across Hong Kong and Mainland China. The company's healthcare division delivers diagnostic advisory services, medical examination and testing, and the supply of health-related supplements. Furthermore, Zhong Ji Longevity is involved in holding equity stakes, investing in both short and long-term financial instruments, offering financial and investment advisory, and property acquisition. It also extends health advisory services and deals in medical commodities. Founded in 1994, the company was formerly known as Asia Pacific Silk Road Investment Company Limited before rebranding to its current name in March 2021. Its main office is situated in Causeway Bay, Hong Kong.
Prix de l'action
$0.06268385
Capitalisation boursière
$39.91M
Changement (1 jour)
25.64%
Changement (1 an)
-21.02%
Pays
HK
Échange Zhong Ji Longevity Science Group Limited (0767)
Bénéfices pour Zhong Ji Longevity Science Group Limited (0767)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Zhong Ji Longevity Science Group Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Zhong Ji Longevity Science Group Limited de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$26.96B -
US
$20.17B -
US
$14.76B -
US
$13.00B -
US
$3.05B -
IN